Risk of Neutropenia with the Use of Ceftaroline: A Review
Samah Qasmieh, Joelle Ataessien, Monique House, Shakib Zegar, Tuiana Brown and Ryan Davidson
Article Type: Review Article | First Published: 2023/07/19
Ceftaroline is a fifth-generation cephalosporin with activity against methicillin-resistant Staphylococcus aureus (MRSA), which is a clinically distinct feature for a member of this class. Cephalosporins have previously been associated with neutropenia, a serious hematologic condition with an absolute neutrophil count (ANC) falling below 1500-1800 cells/μL. Since its FDA approval in 2010, ceftaroline has been associated with neutropenia in several studies. ...
Coping with the Ongoing SARS-CoV-2 Pandemic and Seasonal Influenza
Mujahed I Mustafa and Ahmed Mohammed
Article Type: Commentary Article | First Published: 2023/05/31
The ongoing SARS-COV-2 pandemic has brought about unprecedented challenges to individuals, communities, and healthcare systems worldwide. As the world braces for a potential second wave of COVID-19 infections, the seasonal influenza season is also looming. This article explores the coping strategies that individuals and healthcare systems can adopt to manage both the SARS-COV-2 pandemic and seasonal influenza. ...
Erythema Induratum of Bazin: A New Case
Najoua Ammar, Mariame Meziane, Nadia Ismaili, Laila Benzekri and Karima Senouci
Article Type: Case Report | First Published: 2023/05/31
Erythema induratum of Bazin (EIB) is a rare skin form of tuberculosis (TB) that is most commonly seen in middle-aged women. Clinically, EIB can mimic several skin conditions, which often leads to a delay in diagnosis. We report here the observation of a new case of EIB, presenting as a chronic nodular panniculitis, in a 38-year-old female patient....
Surveillance for Recent Infection among Newly Diagnosed Persons Living with HIV in Nigeria: The Implication for Epidemic Control
Moses Katbi, Amalachukwu Ukaere, Adefisayo Adedoyin, Maryam Bello, Adeoye Adegboye, Helina Meri, Angela Agweye and Rachel Goldstein
Article Type: Research Article | First Published: 2023/05/31
HIV recency is used to distinguish between a recent HIV infection i.e., within the last 12 months, and a long-term HIV infection. In the era of test and treat, identifying and preventing new HIV infections in undiagnosed individuals remains a high priority in our response to the epidemic especially in effectively interrupting HIV transmission within the population. Recent infection assay helps to diagnose people with a recent infection which ultimately helps to identify/map out active infection ...